Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00399893 · ClinicalTrials.gov registry record · NA
Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS)
A NA study, sponsored by Duke University.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT00399893: Clinical Trial NA study, sponsored by Duke University.
NCT00399893 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00399893, a NA study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate over a 6 month period the effect of octreotide therapy on food intake, sense of hunger, body weight, body composition, efficiency of burning calories, biomarkers of weight regulation and growth hormone markers in children and young Adults with Prader-Willi Syndrome(PWS).
Primary Outcome
Number of participants showing a decrease in Fasting total ghrelin from baseline to 6 months of treatment with Octreotide or placebo
Interventions
- DRUG Placebo
- DRUG Octreotide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2006-12 |
| Est. Completion | 2010-09 |
| Phase | NA |
Why NCT00399893 stopped before completion
NCT00399893 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00399893 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00399893 about?
NCT00399893 is a clinical study titled "Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS)". The purpose of this study is to investigate over a 6 month period the effect of octreotide therapy on food intake, sense of hunger, body weight, body composition, efficiency of burning calories, biomarkers of weight regulation and growth hormone markers in children and young Adults with Prader-Willi...
What is the current status of trial NCT00399893?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2006-12. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00399893?
The interventions under investigation include: Placebo (DRUG), Octreotide (DRUG).
Who is sponsoring clinical trial NCT00399893?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00399893's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia